Cargando…
Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia
BACKGROUND: Mesenchymal stem cells (MSCs) attenuate lung injury in experimental models of bronchopulmonary dysplasia (BPD). Stromal derived factor-1 (SDF-1), a chemokine secreted by MSCs, modulates angiogenesis and stem cell recruitment. Here we tested the hypothesis that SDF-1 mediates MSC protecti...
Autores principales: | Reiter, Joel, Drummond, Shelley, Sammour, Ibrahim, Huang, Jian, Florea, Victoria, Dornas, Polliana, Hare, Joshua M., Rodrigues, Claudia O., Young, Karen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506612/ https://www.ncbi.nlm.nih.gov/pubmed/28701189 http://dx.doi.org/10.1186/s12931-017-0620-z |
Ejemplares similares
-
Intra-tracheal administration of a naked plasmid expressing stromal derived factor-1 improves lung structure in rodents with experimental bronchopulmonary dysplasia
por: Guerra, Kasonya, et al.
Publicado: (2019) -
Mesenchymal stromal/stem cells and bronchopulmonary dysplasia
por: Zhang, Shuqing, et al.
Publicado: (2023) -
Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
por: Möbius, Marius A., et al.
Publicado: (2016) -
Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia
por: Zhang, Zhaohua, et al.
Publicado: (2018) -
Mesenchymal Stromal Cell Extracellular Vesicles: A New Approach for Preventing Bronchopulmonary Dysplasia?
por: Klinger, James R., et al.
Publicado: (2022)